Risperdal Verdicts Contested by Janssen, Plaintiffs
The Legal Intelligencer, Dec 23, 2015: Janssen, Plaintiffs Sparring Over Risperdal Verdicts In the wake of several Risperdal trials going to verdict this year, parties on both sides of the litigation are contesting the amounts juries awarded. In recent post-trial filings in two Risperdal cases, Janssen Pharmaceuticals has argued the verdicts, both of which were […]
BREAKING: $1.75M Verdict
A $1.75 million verdict in a Sheller firm antipsychotic drug Risperdal case was awarded today in Pennsylvania in the fourth case alleging Johnson & Johnson failed to warn of the risks of gynecomastia, the development of female-like breasts in boys and young men. The jury found the drug was a “substantial factor” in causing a […]
STEPHEN SHELLER LIFETIME ACHIEVEMENT AWARD
Stephen Sheller was honored with a Lifetime Achievement Award Wednesday, May 20 2015 from American Lawyer Media’s daily newspaper, The Legal Intelligencer. The award was based on his record of verdicts and settlements, service to clients, dedication to the practice, and support of legal education. The Legal Intelligencer, May 20, 2015: “Stephen A. Sheller […]
Legal Intelligencer Quotes Sheller on Risperdal Suit Filings
The Legal Intelligencer 2014-01-15 Individual suit filings related to the antipsychotic drug Risperdal have been increasing in the Philadelphia Court of Common Pleas, First Judicial District leaders say. The uptick has been steady since actions against Johnson & Johnson and its subsidiaries began four years ago, according to the court officials. “We have a group […]
